Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?
- 1 August 1994
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 19  (4) , 203-215
- https://doi.org/10.1016/0732-8893(94)90033-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 1994
- North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin: A 53-medical-center sample of spectra of activityDiagnostic Microbiology and Infectious Disease, 1994
- The north american component (the united states and canada) of an international comparative MIC trial monitoring ofloxacin resistanceDiagnostic Microbiology and Infectious Disease, 1993
- Ofloxacin, a new broad-spectrum fluoroquinolone results from a multicenter, national comparative activity surveillance studyDiagnostic Microbiology and Infectious Disease, 1992
- Review of Preclinical Studies with OfloxacinClinical Infectious Diseases, 1992
- OfloxacinDrugs, 1991
- Antimicrobial activity of cefpirome an update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centersDiagnostic Microbiology and Infectious Disease, 1991
- CiprofloxacinDrugs, 1988
- Clinical importance of inducible beta-lactamases in gram-negative bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- OfloxacinDrugs, 1987